Crystal structure of human uroporphyrinogen III synthase

Uroporphyrinogen III synthase, U3S, the fourth enzyme in the porphyrin biosynthetic pathway, catalyzes cyclization of the linear tetrapyrrole, hydroxymethylbilane, to the macrocyclic uroporphyrino gen III, which is used in several different pathways to form heme, siroheme, chlorophyll, F430 and vitamin B12. U3S activity is essential in all organisms, and decreased activity in humans leads to the autosomal recessive disorder congenital erythropoetic porphyria. We have determined the crystal structure of recombinant human U3S at 1.85 Å resolution. The protein folds into two α/β domains connected by a β‐ladder. The active site appears to be located between the domains, and variations in relative domain positions observed between crystallographically independent molecules indicates the presence of flexibility that may be important in the catalytic cycle. Possible mechanisms of catalysis were probed by mutating each of the four invariant residues in the protein that have titratable side chains. Additionally, six other highly conserved and titratable side chains were also mutated. In no case, however, did one of these mutations abolish enzyme activity, suggesting that the mechanism does not require acid/base catalysis.

[1]  A. Battersby.  Ideas and experiments in biosynthesis. , 2008, Ciba Foundation symposium.

[2]  S. Yamashita,et al.  Congenital erythropoietic porphyria: a novel homozygous mutation in a Japanese patient. , 2000, The Journal of investigative dermatology.

[3]  K D Cowtan,et al.  Density modification for macromolecular phase improvement. , 1999, Progress in biophysics and molecular biology.

[4]  Herrera Saval,et al.  Congenital erythropoietic porphyria affecting two brothers , 1999, The British journal of dermatology.

[5]  Thomas C. Terwilliger,et al.  Automated MAD and MIR structure solution , 1999, Acta crystallographica. Section D, Biological crystallography.

[6]  H. Namba,et al.  Novel point mutation in the uroporphyrinogen III synthase gene causes congenital erythropoietic porphyria of a Japanese family. , 1997, American journal of medical genetics.

[7]  Gérard Bricogne,et al.  SHARP: maximum-likelihood refinement of heavy-atom parameters in the MIR and MAD methods , 1996 .

[8]  T. Cox.  The metabolic and molecular bases of inherited disease: Vols I, II and III (7th edn): edited by Charles R. Scriver, Arthur L. Beaudet, William S. Sly and David Valle McGraw-Hill, 1995, £195.00 hbk (4605 pages) ISBN 0 07 909826 6 , 1996 .

[9]  A G Murzin,et al.  SCOP: a structural classification of proteins database for the investigation of sequences and structures. , 1995, Journal of molecular biology.

[10]  R. Matthews,et al.  How a protein binds B12: A 3.0 A X-ray structure of B12-binding domains of methionine synthase. , 1994, Science.

[11]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[12]  B. Atshaves,et al.  Studies On uro'gen III synthase with modified bilanes , 1994 .

[13]  B. Atshaves,et al.  Evidence for an intermediate in the enzymatic formation of uroporphyrinogen III. , 1994, Bioorganic & medicinal chemistry.

[14]  A. Ian Scott,et al.  How Nature Synthesizes Vitamin B12 ? A Survey of the Last Four Billion Years , 1993 .

[15]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[16]  V. Ramakrishnan,et al.  Crystal structure of globular domain of histone H5 and its implications for nucleosome binding , 1993, Nature.

[17]  R. Desnick,et al.  Congenital erythropoietic porphyria: identification and expression of exonic mutations in the uroporphyrinogen III synthase gene. , 1992, The Journal of clinical investigation.

[18]  M. Carson.  RIBBONS 2.0 , 1991 .

[19]  R. Huber,et al.  Accurate Bond and Angle Parameters for X-ray Protein Structure Refinement , 1991 .

[20]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[21]  Finian J. Leeper,et al.  Biosynthesis of the pigments of life: mechanistic studies on the conversion of porphobilinogen to uroporphyrinogen III , 1990 .

[22]  Desmond G. Higgins,et al.  Fast and sensitive multiple sequence alignments on a microcomputer , 1989, Comput. Appl. Biosci..

[23]  S. Tsai,et al.  Human uroporphyrinogen III synthase: molecular cloning, nucleotide sequence, and expression of a full-length cDNA. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[24]  S. Tsai,et al.  Purification and properties of uroporphyrinogen III synthase from human erythrocytes. , 1987, The Journal of biological chemistry.

[25]  W. Kabsch,et al.  Dictionary of protein secondary structure: Pattern recognition of hydrogen‐bonded and geometrical features , 1983, Biopolymers.

[26]  K. Wilson,et al.  Efficient anisotropic refinement of macromolecular structures using FFT. , 1999, Acta crystallographica. Section D, Biological crystallography.

[27]  I. Glass,et al.  Molecular Genetics of Congenital Erythropoietic Porphyria , 1998, Seminars in liver disease.

[28]  Chris Sander,et al.  Dali/FSSP classification of three-dimensional protein folds , 1997, Nucleic Acids Res..

[29]  G. Bricogne,et al.  [27] Maximum-likelihood heavy-atom parameter refinement for multiple isomorphous replacement and multiwavelength anomalous diffraction methods. , 1997, Methods in enzymology.

[30]  F. Leeper.  The evidence for a spirocyclic intermediate in the formation of uroporphyrinogen III by cosynthase. , 1994, Ciba Foundation symposium.

[31]  F. Leeper,et al.  Synthetic studies on the proposed spiro intermediate for biosynthesis of the natural porphyrins: the stereochemical probe , 1991 .

[32]  W. Stark,et al.  Synthetic studies on the proposed spiro intermediate for biosynthesis of the natural porphyrins: inhibition of cosynthetase , 1986 .

[33]  M. Meegan,et al.  Biosynthesis of type-III porphyrins: proof of intact ezymic conversion of the head-to-tail bilane into uro'gen-III by intramolecular rearrangement , 1978 .